Latest filing published 22 Dec 2024 for InMed Pharmaceuticals Inc..
Insider track record
No signal scores available.
Eric Chih-Hsien Hsu: trading record in brief
All filings by Eric Chih-Hsien Hsu on record concern InMed Pharmaceuticals Inc. We count 2 filings; the first trade dates from 7 September 2022 and the latest from 14 November 2024.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 22 December 2024, the filings show a transaction in InMed Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eric Chih-Hsien Hsu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 49 sharesCommon SharesTSXSEDI:4423059
- 1,221 sharesCommon SharesTSXSEDI:4017830
2 of 2 declarations
